Hepregen Corporation

Category Archives

Hepregen Launches First Dual-Species HepatoPac™ DMPK Assay Kits for Metabolite Identification and Profiling

Hepregen Corporation, leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based assay products, announced today the commercial Read more...

Hepregen Launches First Human HepatoPac™ Assay Kit to Evaluate Metabolic Stability

Application-Directed Kit Provides Accurate Information to Developers of Pharmaceuticals, Cosmetics, and All New Chemical Entities Medford, Massachusetts Read more...

Hepregen Launches First Monkey HepatoPac™ Assay Kits at Annual User Group Meeting

Today, at the Company’s annual User Group Meeting, Hepregen Corporation, leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based Read more...

Hepregen Launches Multi-Donor Human HepatoPac™ Assay Kits at 10th Annual ISSX Meeting

Today, at the annual meeting of the International Society for the Study of Xenobiotics (“ISSX”), Hepregen Corporation, leader in the development of Read more...

QPS Holdings LLC and Hepregen Corporation Announces hepatopactm Commercial Partnership

Agreement Provides for Co-Promotion, Marketing and Sales of Services Utilizing Hepregen’s Proprietary HepatoPacTM Products for Drug Metabolism and Pharmacokinetic Read more...

Hepregen Announces Issuance of its First Patent Protecting Manufacturing Methods of Hepatopactn and Related Products

Issued Claims Add Years of Protection for Unique, Paradigm-Shifting HepatoPacTM Products Medford, MA, May 28, 2013 – Hepregen Corporation announced Read more...

Qualyst Transporter Solutions, LLC and Hepregen Corporation Execute Letter of Understanding

Agreement Provides First Step to Partnering Arrangement Supporting Use of Qualyst’s Patented B-CLEAR® Technology in Combination with Hepregen’s Read more...

Hepergen Corporation Receives National Science Foundation Grant

HEPREGEN CORPORATION RECEIVES NATIONAL SCIENCE FOUNDATION GRANT UNDER SBIR PHASE II-B PROGRAM Grant Funding will Support Continued Development of HepatoPacTM Read more...

Hepergen Corporation And Partners Present Findings At Key Research Meeting

HepatoPac™ Liver Model is Touted for its Value to Predict Clinical Parameters of Commercially Available Drugs  Medford, MA, November 2, 2011 – At Read more...

Hepergen Corporation Awarded Massachusetts Life Sciences Center 2011 Small Business Matching Grant

HEPREGEN CORPORATION AWARDED MASSACHUSETTS LIFE SCIENCES CENTER 2011 SMALL BUSINESS MATCHING GRANT Company receives $500,000 grant; continues growth Read more...

Page 1 of 212

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184